Ezetimibe is more gut-specific than statins and is less likely to harm mitochondria based on its physiological mechanisms, since it targets intestinal cholesterol absorption rather than systemic metabolic pathways.
causalpending
Evidence Quote
“This medication, in my opinion, based on the physiological mechanisms, is less likely to harm your mitochondria. It's more gut-specific.”
Created: 8/12/2026, 2:28:10 AM
Your notes
Loading notes...